关于抗血栓性作用的案例报告
Simone C Boedecker-Lips1, Katharina Batzke2, Pascal Klimpke1
1Department of Nephrology, University Medical Centre Mainz, Johannes Gutenberg University Mainz, Mainz, Germany.
新的Toray FiltryzerTM-NF血液透析过器允许减少抗凝血,甚至在某些情况下完全省略. 这种新型过器对于有出血风险的患者来说是安全有效的.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物材料科学 生物材料科学
背景情况:
- 介绍Toray FiltryzerTM-NF,一种新型的聚甲基甲酸过器.
- 这种过器显示出增强的血红相容性和对血小板数的影响最小.
研究的目的:
- 用Toray FiltryzerTM-NF.评估在血液透析期间降低抗凝血的可行性.
- 评估该过器在有对全方位抗凝药的禁忌的患者中的安全性和有效性.
主要方法:
- 在5名患者进行了血液透析,这些患者对使用FiltryzerTM-NF.完全抗凝剂有禁忌.
- 患者包括患有术后或脏活检后疾病的患者.
主要成果:
- 观察到肝素给药的显著减少.
- 一名患者完成了血液透析,没有任何肝素替代.
- 尽管降低了肝化,但没有发生系统血栓形成的情况.
结论:
- 使用Toray FiltryzerTM-NF进行血液透析是患有高出血风险的患者的可行替代方案.
- 过器促进了有效的透析,同时最大限度地降低了抗凝血要求.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
07:08Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
Published on: September 5, 2017
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
